Pricing Log in Create free account

Cognition Therapeutics, Inc. (CGTX) vs MediciNova, Inc. (MNOV)

Cognition Therapeutics, Inc. and MediciNova, Inc. are both Biotechnology companies. Cognition Therapeutics, Inc. and MediciNova, Inc. are of similar size ($71.4M and $69.7M). Cognition Therapeutics, Inc. has the higher net margin (0.00% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 13 metrics below, MediciNova, Inc. leads on 7 and Cognition Therapeutics, Inc. on 6.

Valuation

Metric CGTX MNOV Biotechnology median
P/E n/m n/m 8.50
P/S n/m 75.94 9.71
P/B 2.00 1.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 48.32 9.21
Earnings yield (23.29%) (14.79%) (33.15%)
Free cash flow yield (26.75%) (13.05%) (25.50%)

Profitability

Metric CGTX MNOV Biotechnology median
Gross margin 0.00% 37.76% 65.16%
Operating margin 0.00% (1,287.53%) 0.00%
Net margin 0.00% (1,168.31%) 0.00%
Free cash flow margin 0.00% (991.31%) 0.00%
Return on equity (83.76%) (25.56%) (56.36%)
Return on assets (57.33%) (23.83%) (48.04%)
Return on invested capital 0.00% (62.48%) 0.00%

Growth

Metric CGTX MNOV Biotechnology median
Revenue growth (TTM) — (82.20%) 6.02%
EPS growth (last fiscal year) 62.79% (4.35%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGTX MNOV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.03 8.75 4.72
Net debt to EBITDA 0.78 2.32 0.96

Dividend

Metric CGTX MNOV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGTX MNOV Biotechnology median
Market cap 69.67m 71.38m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack